Therefore, along with further optimization of neoantigen prediction algorithm and targeting, a comprehensive understanding of the neoantigen recognition by CD4+ T cells and how that stimulates intratumoral effector and helper function of these T cells will be of utmost importance for the development of personalized immunotherapy targeting individual tumor neoantigens and demands extensive research. This evidence concerns the gene CD4 and neoplasm.